Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy.
Alexander C FanaroffShuang LiGuillaume Marquis-GravelJay GiriRenato D LopesJonathan P PicciniTracy Y WangPublished in: Circulation. Cardiovascular interventions (2021)
Older adults with AF and MI have high incidences of downstream recurrent MI or PCI requiring extended antiplatelet/anticoagulant therapy durations, yet many appear to be under-treated. These results highlight the need for better thrombosis prevention strategies in this group of patients.
Keyphrases
- atrial fibrillation
- coronary artery disease
- percutaneous coronary intervention
- left atrial
- end stage renal disease
- catheter ablation
- oral anticoagulants
- newly diagnosed
- direct oral anticoagulants
- left atrial appendage
- heart failure
- ejection fraction
- acute coronary syndrome
- peritoneal dialysis
- pulmonary embolism
- prognostic factors
- acute myocardial infarction
- cardiovascular disease
- patient reported outcomes
- st segment elevation myocardial infarction
- stem cells
- cardiovascular events
- cell therapy